Modulation of protein-protein interactions with small organic molecules

被引:257
作者
Berg, T [1 ]
机构
[1] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany
关键词
drug design; high-throughput screening; medicinal chemistry; molecular biology; protein-protein interactions;
D O I
10.1002/anie.200200558
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Many proteins exert their biological roles as components of complexes, and the functions of proteins are often determined by their specific interactions with other proteins. Because of the central importance of protein-protein interactions for cellular processes, the ability to interfere with specific protein-protein interactions provides a powerful means of influencing the function of selected proteins within the cell. Cell-permeable small organic modulators of protein-protein interactions are thus highly desirable tools both for the study of physiological cellular processes and for the treatment of numerous diseased states. Herein a number of protein-protein interactions that are considered to be pharmaceutical targets are presented, which will familiarize the reader with the strategies that have been employed for the successful identification of small molecule modulators of these protein-protein interactions. These encouraging examples suggest that combined research efforts in the areas of functional proteomics, assay development, and organic synthesis will open up novel possibilities for the treatment of human diseases in the future.
引用
收藏
页码:2462 / 2481
页数:20
相关论文
共 272 条
  • [21] Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin αvβ3
    Boger, DL
    Goldberg, J
    Silletti, S
    Kessler, T
    Cheresh, DA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (07) : 1280 - 1288
  • [22] Cytokine receptor dimerization and activation: Prospects for small molecule agonists
    Boger, DL
    Goldberg, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) : 557 - 562
  • [23] Self-assembly of β-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates
    Bohrmann, B
    Adrian, M
    Dubochet, J
    Kuner, P
    Müller, F
    Huber, W
    Nordstedt, C
    Döbeli, H
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) : 232 - 246
  • [24] BOLLAG DM, 1995, CANCER RES, V55, P2325
  • [25] Molecular characterization of the hdm2-p53 interaction
    Bottger, A
    Bottger, V
    GarciaEcheverria, C
    Chene, P
    Hochkeppel, HK
    Sampson, W
    Ang, K
    Howard, SF
    Picksley, SM
    Lane, DP
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (05) : 744 - 756
  • [26] Bottger V, 1996, ONCOGENE, V13, P2141
  • [27] Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization
    Bouras, A
    Boggetto, N
    Benatalah, Z
    de Rosny, E
    Sicsic, S
    Reboud-Ravaux, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) : 957 - 962
  • [28] CD4: A co-receptor in the immune response and HIV infection
    Bowers, K
    Pitcher, C
    Marsh, M
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) : 871 - 875
  • [29] THE HERPES-SIMPLEX VIRUS RIBONUCLEOTIDE REDUCTASE IS REQUIRED FOR OCULAR VIRULENCE
    BRANDT, CR
    KINTNER, RL
    PUMFERY, AM
    VISALLI, RJ
    GRAU, DR
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 2043 - 2049
  • [30] Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879